Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OncoGel + Chemoradiation in Esophageal Cancer
NCT00573131Phase 2Terminated
- Sponsor
- Boston Scientific Corporation
- Start
- Jan 2008
- Primary completion
- Nov 2010
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of OncoGel in esophageal cancer, sponsored by Boston Scientific Corporation. Started Jan 2008; status: terminated.
02
Drugs
OncoGel
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00573131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00573131.